Streetbeat News

CHE

Chemed Corporation

https://www.chemed.com

Industry

Medical - Care Facilities

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

RBC Capital analyst Ben Hendrix has maintained an Outperform rating on Chemed (NYSE:CHE) and increased the price target from $604 to $712.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 3:24 pm

Oppenheimer analyst Michael Wiederhorn maintains an Outperform rating on Chemed (NYSE:CHE) and raises the price target from $625 to $650.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 3:37 pm

Chemed (NYSE:CHE) reported Q4 2023 adjusted EPS of $6.60, surpassing the $6.25 estimate, but its sales of $585.91M slightly missed the $586.64M estimate. This represents a 7.18% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:58 pm

Chemed (NYSE:CHE) reported Q4 earnings with an EPS of $6.6, beating estimates by 6.0% against an expected $6.25. Revenue increased by $39.26 million from the previous year. The company has a history of surpassing EPS estimates, leading to a 9.0% share price increase the day after last quarter's earnings announcement.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 9:25 pm

Numerous companies are scheduled to report their earnings on February 27, 2024, covering a wide range of industries from technology and healthcare to energy and financial services. The report includes a mix of expected quarterly losses and earnings, highlighting the diverse financial health and performance outlooks within the corporate landscape.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 10:01 am

Chemed (NYSE:CHE) announced a quarterly dividend of 40 cents per share, with the ex-dividend date set for this Friday. Shareholders owning CHE by the end of Thursday are eligible for the payout, which will be distributed on March 15, 2024.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 2:45 pm

Oppenheimer analyst Michael Wiederhorn has maintained an Outperform rating on Chemed (NYSE:CHE) and increased the price target from $590 to $625.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:58 pm

Chemed Corporation (NYSE:CHE) has announced the appointment of Michael D. Witzeman as the new CFO, effective January 1, 2024. He will succeed David P. Williams upon his retirement. Witzeman, currently the Vice President and Controller at Chemed, has been with the company since 2005 and has a background in accounting and assurance from Deloitte & Touche LLP.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 6:26 pm

Chemed's CFO, Patrick David Williams, has sold 6,000 shares at an average price of $583.85 per share, according to a Form4 filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 4:40 pm

Chemed (NYSE:CHE) has announced a quarterly dividend of 40 cents per share, payable on December 04, 2023. The stock will go ex-dividend on Friday, meaning it will likely open 40 cents lower. Shareholders owning CHE by the end of Thursday's session will be eligible for the dividend.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 2:45 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.